Delivery Order SPE2DB22D1103-SPE2DB24FTFG6

Award Date 2/15/24
Potential Completion Date 2/16/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, valued at $1,078.01. The contract is for the supply of the medication FOSAMAX 70 MG TABLET UU 4S, with a completion date of February 20, 2024. This award is under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,044.32 contract is for the supply of FOSAMAX 70 MG TABLET medication. This award is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to provide pharmaceutical products and medical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide FOSAMAX 70 mg tablets. The contract, valued at $8,411.96, has a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the pharmaceutical product to the agency. This delivery order is issued under a larger indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,364.33 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Fosamax 70 mg tablets to support military medical treatment facilities. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential...
The Defense Logistics Agency awarded a $1,981.08 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide FOSAMAX 70 MG tablets. The contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $6,074.73 firm fixed price delivery order is for the supply of FOSAMAX 70 MG TABLET medication. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania. The $26,739.50 firm fixed price delivery order is for the supply of FOSAMAX 70 MG Tablet, a pharmaceutical product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,013.89 to Amerisourcebergen Drug Corp's Corporate Office division. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic,...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FOSAMAX 70 MG TABLET, a pharmaceutical product, and has a ceiling value of $8,494.60. The contract is a firm-fixed-price, delivery order contract with a period of performance through July 2, 2024. The award is not associated with a set-aside program, indicating...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,959.14 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide FOSAMAX 70 MG TABLET. The contract has a completion date of March 7, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract awarded by DLA with a potential value of $999,999,999.00...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTFG6
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide FOSAMAX 70 MG TABLET medical supplies. The contract has a potential value of $1,022.16 and a completion date of February 16, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for delivering pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not have a set-aside designation.

Generated 5/16/24, 10:19 AM